skip to main content skip to accessibility policy


Charles Harding

Partner, Patent Attorney / Southampton

Charles Harding

Practice Areas

Patents - biotechnology, chemistry & pharmaceuticals group
Patent litigation, arbitration & mediation group


Charles represents academic organisations, SMEs and blue chip companies before the UKIPO and the EPO in patent matters in the life sciences sector. His portfolio covers various technologies such as molecular biology, immunology, biotechnology, virology, veterinary science, food science, protein chemistry, chemistry, pharmacology, pharmaceuticals and devices. Charles has an extensive practice in EPO oppositions and appeals, with over 20 years advocacy experience including representation before the EPO Enlarged Board of Appeal. He has been involved in litigation (including first instance and appellate level) in the UK, France, Germany, USA, South Africa and Japan. Charles has also attended interviews at the US Patent Office.

Charles has chaired and/or lectured at numerous international conferences and conventions on life science issues in the patent arena.

Charles became a partner at D Young & Co in 1995. Prior to joining D Young & Co he worked as a patent and trade mark attorney in the chemical and biotechnological industry with Rohm & Haas Company after having gained valuable work experience at Amersham International, Hammersmith Hospital and the Gray Cancer Institute. 


With over 20 years' experience, Charles Harding is also a resolute defender of clients' interests in life sciences oppositions and appeals. IP Stars (MIP).

Charles "garners plaudits for his savvy approach to prosecution from sources as far away as Australia" Legal 500.

Charles "represents academic and research institutions, emerging businesses and multinational corporations in patent oppositions and litigation concerning the life sciences and medical research fields" Chambers.

"A leading patent attorney with a great deal of experience in the life sciences sector. Clients say he is 'excellent at both oral proceedings and high-pressure cases" Chambers.

A "great sense of the big picture", "excellent understanding of clients' commercial interests" Legal 500.

"Clearly in the premier league of patent attorneys covering biotech in the UK" Managing IP. 


BSc Hons Chemistry and Biochemistry, Imperial College.
PhD in medical research, University of London (MRI contrast agents).
European Patent Attorney 1991.
Chartered Patent Attorney 1990.
European Design Attorney.


Chartered Institute of Patent Attorneys (CIPA).
European Patent Institute (epi).
Royal Society of Chemistry (RSC).
Royal Society of Medicine (RSM).

Selected Publications

World IP Review 2008 “Patentable Inventions”.
European Patent Office’s Eposium 1992 Genetic Engineering – The New Challenge; Special Recognition Award “Of rodents and elephants (a week in the life of the European patent in the name of A. Shrew Co.)”.
CIPA article on exhaustion of rights.
Runner-up Daily Telegraph Young Science Writer of the Year Award.
Bligh SW, Harding CT, Sadler PJ, Bulman RA, Bydder GM, Pennock JM, Kelly JD, Latham IA, Marriott JA. “Use of paramagnetic chelated metal derivatives of polysaccharides and spin-labelled polysaccharides as contrast agents in magnetic resonance imaging.” Magn Reson Med. 1991 Feb;17(2):516-32.
Named inventor on at least the following patents: EP patent No. 0210043, EP patent No. 0236411, EP patent No. 0183760, US patent No. 4880007, US patent No. 5250672 and US patent No. 5401491.
Former contributor to the CIPA Guide to the Patents Act.


Follow us

Newsletter subscriptions

In support of our environmental policy we encourage email subscriptions to receive our patent and trade mark newsletters as soon as they are published. Please send your contact details to

For RSS users

Our RSS news feeds allow you to see when we have added new content to our website so you can get the latest site updates in one place, as soon as they are published.

Social media

Privacy Policy

We are committed to protecting and respecting your privacy. To understand our views and practices regarding your personal data and how we will treat it please see